BURLINGAME, Calif.--(BUSINESS WIRE)--VistaGen Therapeutics, Inc., a platform-enabled biopharmaceutical company using embryonic stem cell technologies for drug discovery and development, has named Matthew W. Kalnik, Ph.D., as Executive Vice President, Head of Business Development.
